Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin?
about
Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Should anticoagulation therapy ...... low-molecular weight heparin?
@en
Should anticoagulation therapy ...... low-molecular weight heparin?
@nl
type
label
Should anticoagulation therapy ...... low-molecular weight heparin?
@en
Should anticoagulation therapy ...... low-molecular weight heparin?
@nl
prefLabel
Should anticoagulation therapy ...... low-molecular weight heparin?
@en
Should anticoagulation therapy ...... low-molecular weight heparin?
@nl
P356
P1476
Should anticoagulation therapy ...... low-molecular weight heparin?
@en
P2093
Edgar Gerardo Urrego
Enrique González-Billalabeitia
P356
10.1200/JCO.2014.60.6384
P407
P577
2015-04-13T00:00:00Z